Novo Nordisk announced a $506 million investment to expand its manufacturing facility in Monksland, Athlone, Ireland, significantly increasing production capacity for current and future GLP-1 ...

(Corrects headline to $506 million, not $470 million; corrects text to 432 million euros, not more than 400 million) ...

- Largest manufacturing scale to date achieved by combining four 4,000-liter single-use bioreactors DUNDALK, Ireland, Jan. 31, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading ...

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

A UL and IMR partnership will facilitate the design and development of Ireland's first additive manufactured liquid rocket engine.

Amid an influx of U.S. investments, geopolitical uncertainties support the need for manufacturing projects in other regions, IDA Ireland's Rory Mullen told Fierce.

INDIANAPOLIS, Sept. 12, 2024 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced a $1 billion expansion of its Limerick, Ireland, manufacturing site to increase production of biologic active ...

Investing.com -- Ireland’s manufacturing sector gained momentum in February, with the AIB Ireland Manufacturing PMI rising to 53.1 from 52.2 in January, marking the strongest improvement in business ...

New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end of 2027 i Demand for CT and X-Ray contrast media, ...

In today’s Pharmaceutical Executive Daily, industry leaders examine how to measure AI’s return on investment across the life sciences value chain, Novo Nordisk commits $506 million to expand its ...

- First manufacturing run successful for MFG7 facility at the Ireland site- Largest manufacturing scale to date achieved by combining four 4,000-liter single-use bioreactors The manufacturing run ...